期刊文献+

良性前列腺增生与动脉粥样硬化的关系 被引量:3

A correlation between benign prostate hyperplasia and atheroselerosis
原文传递
导出
摘要 目的探讨良性前列腺增生(BPH)与动脉粥样硬化(AS)的内在联系和发病机制。方法依据前列腺体积(PV)将95例患者分为非BPH组(PV≤20ml)24例和BPH组(PV〉20ml)71例。采用高分辨率彩色多普勒超声测定颈动脉内膜中层厚度(IMT),采集相关数据进行分析。结果BPH组三酰甘油(TG)、超敏C反应蛋白(hsCRP)、空腹血清胰岛素的对数[ln(FINS)]、胰岛素抵抗指数的对数[ln(HOMA—IR)]、IMT均显著高于非BPH组,BPH组的冠心病、脑动脉硬化患病率44%、45%,显著高于非BPH组18%、11%(χ^2=6.532、10.162,均P〈0.05)。相关分析显示PV与ln(FINS)、ln(HOMA—IR)、TG、高密度脂蛋白胆固醇(HDLC)呈正相关(r=0.204、0.196、0.375、0.383,均P〈0.05)。结论BPH与AS具有相关性,胰岛素抵抗、炎性反应和血管内皮功能失调可能是BPH和AS共同的发病机制。 Objective To investigate the correlation between benign prostate hyperplasia (BPH) and atheroselerosis (AS). Methods 95 cases were divided into two groups based on prostate volume (PV) : 24 cases with non-BPH (PV≤20 ml) and 71 cases with BPH (PV≥20 ml). Carotid intinal medial thickness (IMT) was determined by high resolution color Doppler sonography. Results Levels of triglyceride (TG), hypersensitive C reactive protein (hs CRP), in fasting insulin [ln (FINS)], in insulin resistance index [ln (HOMA IR)] and IMT in BPH group were significantly higher than in nomBPH group. The morbidity rate of coronary heart disease and cerebral arteriosclerosis in the BPH group enhanced as compared with non BPH group. PV were positively correlated with In(FINS), In(HOMA IR) ,TG and high density lipoprotein (HDL-C). Conclusions BPH is closely correlated with AS and their eo-pathogenesis might be insulin resistance, inflammatory reaction and endothelial dysfunction.
作者 高璐 秦明照
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2011年第11期919-920,共2页 Chinese Journal of Geriatrics
关键词 前列腺增生 动脉粥样硬化 Prostatic hyperplasia Atherosclerosis
  • 相关文献

参考文献4

  • 1杨勇.良性前列腺增生内科综合治疗的必要性和可能存在的问题[J].中华老年医学杂志,2010,29(11):881-882. 被引量:11
  • 2OzdenC, Ozdal OL, Urgancioglu G, el al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol, 2007,51 : 199 206.
  • 3Nandeesha H, Koner BC, Dorairajan LN, et al. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta, 2006, 370=89 93.
  • 4Rohrmann S, De Maxzo AM, Smit E, et al. Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES [1I). Prostate,2005,62:27 33.

二级参考文献6

  • 1Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol,1984,132:474-479.
  • 2Giovannucci E, Rimm EB, Chute CG et al. Obesity and benign prostatic hyperplasia. Am J of Epidemiol, 1994,140:989-1002.
  • 3Parsons JK, Bergstrom J , Barrett-Connor E. Lipids, lipoproteins, and risk of benign prostatic hyperplasia in community dwelling men. BJU Int, 2008, 101: 313-318.
  • 4Boyle P. Epidemiology of benign prostatic hyperplasia: risk factors and concomitance with hypertension. Br J Clin Pratt Suppl,1994 ,74:18-22.
  • 5Parsons JK, Carter liB, Partin AW. Metabolic factors associated with benign prostatic hyperplasia. J Clin Enclocrinol Metab,2006,91: 2562-2568.
  • 6Souverein PC, Erkens JA, de la Rosette J J, et al. Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery. Eur Uroi, 2003,43:528-534.

共引文献10

同被引文献40

  • 1洪鸣鸣.良性前列腺增生症和内科疾病的关系[J].中华老年医学杂志,2006,25(11):807-808. 被引量:10
  • 2于普林,钱芸娟.良性前列腺增生患病情况概述[J].中华老年医学杂志,2006,25(11):870-872. 被引量:23
  • 3张祥华,王行环,王刚,等.良性前列腺增生诊断治疗指南//那彦群,孙光.中国泌尿外科疾病诊断治疗指南.北京:人民卫生出版社,2009:103-119.
  • 4Hammarsten J, Hogstedt B. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis, 1998, 1:157-162.
  • 5Wheatcroft SB, William IL, Shah AM, et al. Pathophysiological implications of insulin resistance on vascular endothelial {unction. Diabet Med, 2003, 20:255-268.
  • 6Shirai K,Utino J, Otsuka K, et al. A novel blood pressure-independent arterial wall stiffness parameter: cardio-ankle vascular index (CAVI). Journal of Atherosclerosis Thrombosis, 2007, 13:.
  • 7Chen I, Tsai YS, Tong YC, et al. Correlations among cardiovascular risk {actors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia. Urology, 2011, 79= 409-414.
  • 8BergerAP, Deibl M, Leonhartsberger N, et al. Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction. BJU Int, 2005, 96:1073 1078.
  • 9Schuster A, Pinggera G, Pallwein L, et al. Assessment of transectal color Doppler ultrasound (TRCDUS) for measurement o{ urinary bladder neck blood flow in a porcine model., comparison to laser Doppler flowmetry. Eur Rodiol, 2003 (Suppl 1 ) $315-316.
  • 10Yanes LL, Sartori Valinotti JC, Iliescu R, et al. Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats. Am J Physiol Renal Physiol, 2009, 296:771-779.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部